Hasil Pencarian
	Ditemukan 1748 dokumen dengan kata kunci 5093 Simpan CSV  Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC) No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1615-1622 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p54-59 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1630-1639 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.67-74 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1543-1548 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer No. Panggil: Annals of Oncology; Volume 24, No.1, January 2013, p.59-66 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.9, 1 May, 2013: p.595-605 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2335-2341 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.679-687 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer No. Panggil: Annals of Oncology; Volume 24, No.2, February,2013,p.314-321 | Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  :: Prev   1 2 3 4 5 6 7 8 9 10  Next